(Total Views: 460)
Posted On: 02/27/2020 9:01:50 PM
Post# of 155002
It's OTC but it goes deeper than that. FTSV has 78% insitutional owernship. CYDY has 0%. We have absolutely no credibility. It is in nobody's interest to give CYDY creditability. Our HIV partner has no credibility to give. The CEO continues to miss his own deadlines which crushes his credibility even with those that know and want to trust him.
The product (Leronlimab) is simply amazing. Nobody knows about it and the powers that be (BP and others) will keep it that way for as long as possible.
The FDA has the power to deliver credibility. Once it arrives CYDY will be a rocketship.
If Leronlimab was owned by Nasdaq company with respected insititutional ownership, the market cap would be 5 to 10 billion at least. But it's not, we just need something to give that jolt of credibility because right now nobody is paying attention and if they were they wouldn't believe it anyway.
People are sheep they need someone to go first and say, "holy cow this Leronlimab is incredible" It's worth multiple billions. The moment is coming.
The product (Leronlimab) is simply amazing. Nobody knows about it and the powers that be (BP and others) will keep it that way for as long as possible.
The FDA has the power to deliver credibility. Once it arrives CYDY will be a rocketship.
If Leronlimab was owned by Nasdaq company with respected insititutional ownership, the market cap would be 5 to 10 billion at least. But it's not, we just need something to give that jolt of credibility because right now nobody is paying attention and if they were they wouldn't believe it anyway.
People are sheep they need someone to go first and say, "holy cow this Leronlimab is incredible" It's worth multiple billions. The moment is coming.
(2)
(0)
